Lisinopril compositions with an ingestible event marker
US11166939B2 · kind B2 · utility
1Cited by
16References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2018 |
| Grant date | Nov 9, 2021 |
| Priority date | — |
| Expiry date | Apr 25, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2562/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions for the ingestible administration of lisinopril. In some embodiments the compositions comprise lisinopril and silicon. In some embodiments, the compositions comprise lisinopril, silicon, magnesium metal, and copper (I) chloride. Also provided herein are apparatuses comprising the compositions provided herein. Also provided herein are methods for using the compositions and apparatuses provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.